fff
All Blog

Manipal Hospitals IPO: Key Details, GMP Context, And Listing Outlook

Writer
Nidhi Thakur
timer
July 29, 2026
Manipal Hospitals IPO: Key Details, GMP Context, And Listing Outlookblog thumbnail

Key Takeaways

  • Manipal Hospitals IPO comprises a fresh issue of 13.56 crore shares aggregating to Rs 8,000 crore and an OFS of 2.16 crore shares.
  • The price band is Rs 560-590 per share, with an upper price band at Rs 590 and an estimated listing around Rs 600.
  • Grey Market Premium stood at Rs 10 on July 29, signaling muted listing demand.
  • Retail investors can bid in lots of 25 shares; subscription closes July 31; allotment on August 3; listing on August 5.

Manipal Hospitals IPO is shaping up as one of India's largest healthcare listings, but the journey so far has mixed signals. The Rs 9,275 crore public issue opened with a grey market premium of just Rs 10, signaling muted listing enthusiasm from the start. The latest GMP on July 29 stood at Rs 10, underscoring the cautious mood surrounding the listing.

Manipal Hospitals IPO: Key Size, Price Band And Listing Timeline

In detail, Manipal Health Enterprises Ltd is issuing 13.56 crore fresh shares aggregating to Rs 8,000 crore and an OFS of 2.16 crore shares. The price band is Rs 560 to Rs 590 per share, with the upper band implying a near-term listing price around Rs 600. The issue is set to list on NSE and BSE, with allotment expected on August 3 and listing around August 5. Kotak Mahindra Capital Co. Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar. Retail investors can bid for a minimum of one lot of 25 shares, amounting to Rs 14,750 at upper price.

Parameter Value
Fresh Issue Size 13.56 crore shares (Rs 8,000 crore)
Offer For Sale 2.16 crore shares
Price Band Rs 560-590
Upper Price Band Rs 590
Estimated Listing Price About Rs 600
Grey Market Premium Rs 10 (as on July 29)
Open For Subscription Until July 31
Allotment Date August 3
Listing Date August 5
Retail Lot 25 shares
Retail Investment (Upper Price) Rs 14,750
Download App Now
google playapp store

GMP Context And Market Sentiment For Manipal Hospitals IPO

The grey market premium (GMP) for the Manipal Hospitals IPO stood at Rs 10 on July 29, signaling a cautious market mood ahead of listing. While GMP is not official data and can be volatile, it offers a snapshot of near-term sentiment. The implied listing yield based on the cap price plus the GMP suggests a modest premium, which aligns with a wait-and-watch stance among many retail investors in this size of issue.

Use Of IPO Proceeds And Corporate Plans

Proceeds are earmarked primarily for repaying borrowings of the subsidiary, Manipal Hospitals Private Ltd., and to acquire a minority stake in Sahyadri Hospitals Private, along with meeting general corporate purposes. The FY25 total income rose to Rs 10,520.52 crore from Rs 8,362.79 crore in the previous year, while EBITDA rose to Rs 2,795.94 crore from Rs 2,247.07 crore. Profit after tax declined to Rs 916.52 crore from Rs 1,081.67 crore due to higher expenses.

Download App Now
google playapp store

Financial Snapshot: Revenue, EBITDA And Profitability

These metrics illustrate a growth trajectory in revenue but highlight the need to watch cost expansion and debt management as the network scales. Investors should consider whether the implied listing price aligns with the ongoing expansion and the competitive environment in Indian hospital services. The numbers reflect a period of rapid network growth that could translate into improved margins only with careful execution.

Retail Investment Outlook And Subscription Strategy

Retail participants can subscribe in lots of 25 shares, with the window open until July 31. Allotment is expected on August 3 and listing on August 5. For a disciplined approach, investors might set a personal price band and avoid chasing a speculative listing move. For deeper stock analysis, consider Swastika's Sarthi AI stock assistant: Swastika's Sarthi AI stock assistant.

In addition, compare the valuation to peers and consider the potential for post-listing volatility depending on market conditions and sector dynamics within Indian healthcare. The key is to balance the growth potential with the near-term risk and to use a structured framework for subscribing to large IPOs.

Frequently Asked Questions

What is the size and structure of the Manipal Hospitals IPO?

The Manipal Hospitals IPO comprises a fresh issue of 13.56 crore shares aggregating to Rs 8,000 crore and an offer-for-sale of 2.16 crore shares. The price band is Rs 560-590 per share, with the upper price of Rs 590. The listing is expected around August 5 on NSE and BSE after subscription closes on July 31 and allotment on August 3.

What is the price band and the implied listing price for the Manipal Hospitals IPO?

Price Band: Rs 560-590 per share. The upper price band is Rs 590, with an estimated listing price around Rs 600 per share. The grey market premium on July 29 stood at Rs 10, indicating cautious immediate demand, though GMP is speculative and not official.

When is the Manipal Hospitals IPO open, and when will it list?

The IPO is open for subscription until July 31. Allotment is expected on August 3, and listing is anticipated on August 5 on NSE and BSE.

What will the proceeds be used for in the Manipal Hospitals IPO?

The proceeds are planned to repay outstanding borrowings of the subsidiary Manipal Hospitals Private Ltd., acquire a minority stake in Sahyadri Hospitals Private, and meet general corporate purposes.

What are the FY25 financials for Manipal Hospitals as disclosed in the IPO filing?

FY25 total income rose to Rs 10,520.52 crore from Rs 8,362.79 crore. EBITDA rose to Rs 2,795.94 crore from Rs 2,247.07 crore, while profit after tax declined to Rs 916.52 crore from Rs 1,081.67 crore due to higher expenses.

Conclusion

The Manipal Hospitals IPO offers exposure to a large, diversified hospital network with scale and growth potential, but the near-term listing dynamic and pricing require careful risk assessment. For the retail investor, a disciplined approach–anchored to your risk tolerance and a clear view on post-listing performance–will be essential. Consider using Swastika's Sarthi AI stock assistant to stress-test your assumptions and compare with sector peers before subscribing.

Investors should consult a financial advisor for tailored guidance and ensure due diligence on the red herring prospectus before bidding.

Open your trading and demat account here

Reference :

1 : Ndtvprofit

Alert! Missed out on winning option trades? Master the art of successful option buying. Register Now